Transgenic Tg2576 mice expressing human amyloid precursor protein (hAPP) with the Swedish mutation are among the most frequently used animal models to study the amyloid pathology related to Alzheimer's disease (AD). The transgene expression in this model is considered to be neuron-specific. Using a novel hAPP-specific antibody in combination with cell type-specific markers for double immunofluorescent labelings and laser scanning microscopy, we here report that-in addition to neurons throughout the brain-astrocytes in the corpus callosum and to a lesser extent in neocortex express hAPP. This astrocytic hAPP expression is already detectable in young Tg2576 mice before the onset of amyloid pathology and still present in aged Tg2576 mice with robust amyloid pathology in neocortex, hippocampus, and corpus callosum. Surprisingly, hAPP immunoreactivity in cortex is restricted to resting astrocytes distant from amyloid plaques but absent from reactive astrocytes in close proximity to amyloid plaques. In contrast, neither microglial cells nor oligodendrocytes of young or aged Tg2576 mice display hAPP labeling. The astrocytic expression of hAPP is substantiated by the analyses of hAPP mRNA and protein expression in primary cultures derived from Tg2576 offspring. We conclude that astrocytes, in particular in corpus callosum, may contribute to amyloid pathology in Tg2576 mice and thus mimic this aspect of AD pathology.
| INTRODUCTION
Transgenic animal models are essential experimental tools to mimic aspects of Alzheimer's disease (AD) in order to study pathogenic mechanisms and to test therapeutic strategies. Typically, the transgenes are overexpressed and encode mutant forms of disease-related human tau and amyloid precursor (APP) proteins or their processing enzymes (Bodendorf et al., 2002; Hsiao et al., 1996; Oakley et al., 2006; Oddo et al., 2003; Sturchler-Pierrat et al., 1997) . With regard to the amyloid pathology, a large magnitude of human APP (hAPP) constructs with mutations within the Abeta sequence or close to the beta cleavage site of the APP was used to generate transgenic mice that develop AD-typical histopathology. These constructs differ with regard to the hAPP isoform used (APP695, APP751, APP770), the mutations introduced (Swedish, London, Dutch, Florida, Iberian, Arctic, Indiana, Iowa) and the promoter-driving transgene expression (PDGF-β, Thy1, CMV/β-actin, CaMKII-α, prion protein, neuronspecific enolase) . As a result, the onset and degree of amyloid pathology, neuronal and synaptic loss as well as changes in long-term potentiation, neuronal network activity, and the degree of cognitive impairment differ substantially between the animal models established. Thus, it is indispensable to thoroughly characterize each model with regard to cell type and brain region-specific transgene expression patterns. The Tg2576 mouse model was established two decades ago (Hsiao et al., 1996) and had been made broadly available to the scientific community. These mice overexpress hAPP695 carrying the Swedish double mutation KM670/671NL under control of the hamster prion protein promoter and develop amyloid plaques at 11-13 months of age predominantly in neocortex and hippocampus (Hartlage-Rübsamen et al., 2011; Hsiao et al., 1996; Kawarabayashi et al., 2001) . Interestingly, synaptic spine loss in the hippocampal CA1 region (Lanz, Carter, & Merchant, 2003) , changes in hippocampal long-term potentiation (Jacobsen et al., 2006) , hypersynchrony of neuronal network activity (Shah et al., 2016) , and cognitive impairment (King & Arendash, 2002) were reported at 4-6 months of age, indicating the importance of soluble neurotoxic Abeta assemblies or of intracellular APP C-terminal fragments (Xu, Fitzgerald, Nixon, Levy, & Wilson, 2015) present before amyloid plaque pathology.
Another important aspect to explain variability in neuropathology and behavioral disturbances among APP-transgenic mouse lines is the cell type and neuron type-specific expression of hAPP. Both, the hamster prion protein promoter-driving hAPP expression in FVB/N and Tg2576 mice (Hsiao et al., 1995; Hsiao et al., 1996) and transgenic hAPP expression itself were reported to be neuronspecific (Irizarry, Locascio, & Hyman, 2001; Irizarry, McNamara, Fedorchak, Hsiao, & Hyman, 1997) . More specifically in brain, the endogenous hamster prion protein was found to be expressed by neurons of the hippocampus, septum, caudate putamen, thalamic nuclei, and dorsal root ganglia cells (Bendheim et al., 1992) . ). So far, to the best of our knowledge, no glial expression of hAPP in Tg2576 brain was demonstrated. However, using a novel antibody that differentiates between endogenous mouse and hAPP , we here report the presence of nonneuronal cells immunoreactive for hAPP in a brain region-specific manner. To identify the glial cell types expressing the transgene, double immunofluorescent labelings of hAPP with cell type-specific marker proteins were performed in brains of 3-and 18-month-old Tg2576 mice and analyzed by confocal laser scanning microscopy. In addition, primary neurons and glial cells derived from Tg2576 mice were analyzed for hAPP mRNA and protein expression by RT-qPCR and immunocytochemistry, respectively.
Our data indicate that not only neurons, but also astrocytes may contribute to amyloid pathology in the Tg2576 mouse model of AD.
| MATERIALS AND METHODS

| Experimental animals
Breeding pairs of the hAPP-transgenic mouse line Tg2576 were kindly provided by Dr. Karen Hsiao (University of Minnesota). Tg2576 mice were maintained on C57BL/6xSJL background in which transgene expression is driven by the hamster prion protein promoter (Hsiao et al., 1996) . For the characterization of hAPP expression, transgenic Tg2576 mice and their wild type littermates were examined at the postnatal age of 3 and 18 months. Animals were housed in groups of 3-5 animals per cage and separated by sex with food and water ad libitum at 23 C for 12 hr day/12 hr night cycles in cages that contained red plastic houses (Tecniplast, Hohenpeißenberg, Germany) and shredded paper flakes to allow nest building. At the age of 6 weeks, the transgenicity of the animals was tested by polymerase chain reaction of tail DNA, as described elsewhere (Hsiao et al., 1996) .
All experimental protocols were approved by Landesdirektion Sachsen, license T28/16 and all methods were carried out in accordance with the relevant guidelines and regulations.
| Tissue preparation
For immunohistochemistry, adult mice (3 and 18 months of age)
were sacrificed by CO 2 inhalation and transcardially perfused with 50 ml of 0.9% saline followed by perfusion with 50 ml of 4% paraformaldehyde in PB (0.1 M; pH 7.4). The brains were removed from the skull and postfixed by immersion in the same fixative overnight at 4 C. After cryoprotection in 30% sucrose in 0.1 M PB for 3 days, coronal sections (30 μm) were cut at the level of basal forebrain (Bregma 1.10 mm) and hippocampus (−1.80 mm) on a sliding microtome and collected in 0.1 M PB containing 0.025% sodium azide. The specificity and applicability of the 1D1 antibody has been extensively characterized recently . Importantly, using Western blot analyses, robust hAPP bands at approximately 100 kDa were present in brain tissue homogenates of APP-transgenic Tg2576, 3xTg and I5 mice, whereas bands were neither detected at molecular weights of Abeta peptides or C-terminal APP fragments nor in wild type mouse brain tissue (Supporting Information Figure S1 ).
| Double immunofluorescence histochemistry
To reveal the cell type-specific staining generated by the rat monoclo- 
| Confocal laser scanning microscopy
Confocal laser scanning microscopy (LSM 510, Zeiss, Oberkochen,
Germany) was performed to allow allocation of hAPP to neurons, astrocytes, microglia, and oligodendrocytes, respectively in Tg2576 
| Primary glial cells
For the cultivation of glia-rich primary cell cultures, newborn Tg2576 mice were sacrificed by decapitation and brains as well as tail tips for genotyping were collected. The brains were dissociated into single cells by triturating through pipettes of decreasing width and passed through sterile nylon meshes (150 μm). After resuspending the cells with 5 ml astrocyte medium (DMEM supplemented with 10% fetal bovine serum [FBS] , and 1% PSN), 5 ml of each cell suspension were transferred into a T25 cell culture flask and 4 × 500 μl into a 24-well plate containing sterile glass coverslips, respectively. The cells were cultured at 37 C in a humidified atmosphere of 5% CO 2 . The medium was renewed on the third day after seeding and henceforth, once a week.
Between Culture Days 12 and 20, primary microglial cells were separated from the primary astrocytes by subjecting the suspensions to vibrations in a shaking incubator (SI500, Stuart) at 260 rpm and 37 C for 30 min. The cell suspensions were then transferred to new T25 cell culture flasks (5 ml) and 24-well plates (4 × 500 μl) containing sterile glass coverslips, respectively, and were cultured for 3 days under the conditions mentioned above.
For the separation of primary oligodendrocytes, the glia-rich primary cultures were incubated in 5 ml oligodendroglia medium (DMEM supplemented with 1% PSN and 1% N-2 supplement) in a shaking incubator at 220 rpm and 37 C for 18 hr. Afterward, the cell suspensions were split and filled in precoated T25 cell culture flasks (5 ml)
and 24-well cell culture plates (4 × 500 μl) containing precoated, sterile glass coverslips, respectively. Primary oligodendrocytes were cultured for 3 days under the conditions mentioned above.
Subsequently, all primary glial cell cultures in the T25 cell culture flasks were rinsed with ice-cold, sterile PBS, covered with 2.5 ml TRIzol reagent (Invitrogen) and stored at −20 C for cell lysis and RNA extraction at a later time point. The primary glia cultures in the 24-well cell culture plates were fixed with 4% PFA for 10 min and stored in TBS (0.1 M, pH 7.4) at 4 C awaiting immunofluorescent labeling.
| Immunocytochemistry
To determine the cell type-specific expression of transgenic hAPP in primary neuronal and glial cells using the fixed primary cells grown on glass coverslips, double immunofluorescent labelings with 1D1 and cell type-specific antibodies were performed as described for immunohistochemistry on brain sections. Finally, the coverslips were airdried, embedded in entellan/toluene on microscopic slides and stored at 4 C in the dark.
In addition, double labeling with all cell type-specific antibodies was performed in each subculture of neuronal and glial primary cells, to examine the identity and purity of the respective primary cultures (see Supporting Information Figure S2 ).
| RNA isolation and RT-qPCR
To analyze the respective mRNA expression of transgenic hAPP in neuronal and glial primary cell cultures of transgenic Tg2576 mice, reverse transcription quantitative polymerase chain reaction (RT-qPCR) was performed. RNA of cultivated wild type and Tg2576 neurons, astrocytes, microglia, and oligodendroglia was isolated using the TRIzol RNA isolation protocol (Chomczynski & Mackey, 1995) . The specificity of the PCR products was evaluated by melting curves which were generated by a rise in temperature to 84 C. Furthermore, the specificity was tested by separating all samples in agarose gel electrophoresis (2% agarose in TAE [1×] containing 0.01% GelRed) to control correct product length.
| RESULTS
The inspection of Tg2576 mouse brain slices labeled with the antibody 1D1 revealed the expression of hAPP by numerous neurons as described previously . To allow for a comprehen- This glial-like hAPP immunoreactivity is more prominent in corpus callosum compared with parietal cortex, which might be due to the higher density of neuronal cell bodies in cortex. There are no obvious differences in neuronal and glial-like hAPP immunoreactivity between 3-and 18-month-old Tg2576 mice. However, hAPP immunoreactivity was found to be also present in amyloid plaque-associated dystrophic neurites of 18-month-old transgenic mice (Figure 1 ).
To identify the origin of the hAPP immunoreactive glial processes, double immunofluorescent labelings with cell type-specific marker proteins were performed and evaluated by laser scanning microscopy.
In corpus callosum and neocortex of 3-month-old Tg2576 mice without amyloid pathology, hAPP frequently co-localized with the neuronal marker NeuN, but neither with the microglial marker Iba1 nor with the oligodendrocyte marker GSTπ (Figure 2 ). The neuronal expression of hAPP was validated by double labeling of hAPP with the neuronal marker MAP2 (Supporting Information Figure S3A ). However, a substantial proportion of GFAP-immunoreactive astrocytes in corpus callosum and some astrocytes in cortex were found to be hAPPimmunoreactive ( Figure 2 ).
Also in 18 month-old Tg2576 mouse brain, hAPP was localized to neurons and to astrocytes in corpus callosum and cortex, but not to microglia and oligodendroglia (Figure 3 ). Interestingly, in corpus callosum both resting astrocytes distant from amyloid plaques and reactive astrocytes in proximity to amyloid plaques displayed hAPP immunoreactivity, whereas in cortex only nonreactive astrocytes close to or distant from amyloid plaques expressed hAPP immunoreactivity (Figure 3 ). The APP expression by astrocytes was also confirmed by using two alternative antibodies (6E10 and 22C11) in combination with GFAP antibodies (Supporting Information Figure S3B ). However, it should be noted that endogenous mouse APP might have contributed to these signals as 6E10 and 22C11 do not differentiate as well between mouse and transgenic hAPP as does the antibody 1D1.
The robust astrocytic hAPP immunoreactivity raises the question whether hAPP produced by and released from neurons is taken up by astrocytes or whether it is expressed by these glial cells. 
| DISCUSSION
The Tg2576 mouse model developed by Hsiao et al. (1996) is one of the most frequently used animal models to investigate aspects of amyloid pathology, accompanying gliosis as well as functional and behavioral consequences of the formation of pathogenic Abeta assemblies. To completely understand pathogenic mechanisms in this mouse model, a thorough analysis of the brain region and cell typespecific transgene expression is indispensable. A recently developed rat monoclonal antibody differentiating between mouse and human APP allowed for such an analysis and had already been used by us to demonstrate alterations in transgene expression patterns of different hAPP transgenic mouse lines and rats ).
Subsequently, we were able to reveal a spatial correlation between transgene expression and the formation of amyloid plaques (Hartlage-Rübsamen et al., 2018) .
Here, in serial sections immunohistochemically labeled for hAPP, we observed stained cellular structures that did not display neuronal morphology. Glial hAPP expression was already mentioned for FVB/N mice expressing the same promoter or hAPP695s that were constructed, but the glial cell type and brain region-specific occurrence
were not reported (Hsiao et al., 1995) . Therefore, we here analyzed the cell type-specific hAPP expression in young and aged Tg2576 FIGURE 2 Cell type-specific expression of hAPP in brains of 3-month-old Tg2576 mice. The hAPP in corpus callosum and cortex was visualized using the antibody 1D1 and detection with secondary Cy3-conjugated antibodies (red fluorescence) in combination with marker proteins for neurons (NeuN), astrocytes (GFAP), microglia (Iba1), and oligodendrocytes (GSTπ) detected with Cy2-conjugated secondary antibodies (green fluorescence). Note the frequent co-localization of hAPP with neurons and astrocytes (arrows) mouse brain. By immunohistochemical double labelings of hAPP and cell type-specific marker proteins, we demonstrate the expression of hAPP by astrocytes in the corpus callosum and to a much lesser extent in neocortex of young Tg2576 mice without amyloid plaque pathology. In contrast, neither microglial cells nor oligodendrocytes were found to express hAPP.
To rule out that glial immunoreactivity arises from uptake of hAPP produced by neurons, primary glial cultures from Tg2576 offspring were analyzed for hAPP mRNA and protein expression. These experiments confirmed gene expression of hAPP in astrocytes but not in microglial cells and oligodendrocytes.
Our results are corroborated by another study which recently demonstrated that primary cultured astrocytes from Tg2576 mice express transgenic hAPP and secrete Abeta peptides into the culture medium decreasing the number of readily releasable synaptic vesicles and excitatory synaptic transmission in co-cultured neurons (Katsurabayashi et al., 2016) . Moreover, the expression of hAPP in astrocytic Tg2576 cultures and its processing into amyloidogenic fragments were found to be stimulated by addition of oligomeric and fibrillary Abeta preparations, most likely through the stimulation of astrocytic BACE1 expression (Zhao, O'Connor, & Vassar, 2011) . However, in brain tissue of aged Tg2576 mice with robust amyloid pathology, we did not observe an induction of hAPP expression in reactive astrocytes in proximity to Abeta plaques. The reason for this discrepancy is not known but could be based on the application of defined Abeta preparations in cell culture experiments, whereas, in brain tissue, astrocytes are exposed to a broad spectrum of hAPP cleavage products and Abeta peptide variants.
FIGURE 3 Cell type-specific expression of hAPP in brains of 18-month-old Tg2576 mice. The hAPP in corpus callosum and cortex was visualized using the antibody 1D1 and detection with secondary Cy3-conjugated antibodies (red fluorescence) in combination with marker proteins for neurons (NeuN), astrocytes (GFAP), microglia (Iba1), and oligodendrocytes (GSTπ) detected with Cy2-conjugated secondary antibodies (green fluorescence). Note the frequent co-localization of hAPP with neurons and astrocytes (arrows) and the absence of hAPP immunoreactivity in amyloid plaque-associated reactive astrocytes in cortex Nevertheless, the stimulus-dependent capacity of reactive astrocytes to express APP (Avila-Muñoz & Arias, 2015; Siman, Card, Nelson, & Davis, 1989) as well as the APP processing enzyme BACE1 (Hartlage-Rübsamen et al., 2003) and components of the γ-secretase complex (Nadler et al., 2008) indicate a potential astrocytic contribution to amyloid pathology. Indeed, intracellular Abeta was detected in astrocytes of AD cortex (Akiyama et al., 1999) .
As hAPP expression in Tg2576 mouse brain is driven by the hamster prion protein promoter, its expression pattern reflects to a large extent on this promoter activity and may differ drastically from that of the endogenous mouse APP promoter. Hamster prion protein mRNA and protein were reported to be predominantly expressed by neurons, but also by astrocytes, particularly in corpus callosum and optical nerve of hamster and rat (Moser, Colello, Pott, & Oesch, 1995) as well as in cultured mouse primary astrocytes (Lima et al., 2007) . The translation of the endogenous prion protein mRNA in astrocytes was shown to be robust, but not upregulated during reactive astrogliosis in mouse brain (Jackson, Krost, Borkowski, & Kaczmarczyk, 2014) , which might partly explain the lack of hAPP induction in reactive astrocytes in proximity to Abeta plaques of Tg2576 mice. (Golde, Estus, Usiak, Younkin, & Younkin, 1990) and multiple pro-inflammatory cytokines have been shown to upregulate APP expression and Abeta secretion in human astrocyte cultures (Blasko et al., 2000; Brugg et al., 1995) . Astrocytic cell lines and human astrocytes respond with increased APP expression when exposed to TGFβ (Amara, Junaid, Clough, & Liang, 1999; Burton, Liang, Dibrov, & Amara, 2002; Gray & Patel, 1993) , a cytokine which is associated with AD pathogenesis (Luedecking, DeKosky, Mehdi, Ganguli, & Kamboh, 2000) . This implies that TGFβ increases Abeta levels in the AD brain by inducing APP upregulation in astrocytes (Frost & Li, 2017) . In the neuroinflammatory context of AD, reactive astrocytes express higher levels of APP than resting astrocytes and, therefore, could produce more Abeta and contribute to amyloid pathology to a greater extent. Thus, with regard to the induction of hAPP expression by reactive astrocytes, the Tg2576 mouse model clearly differs from the human condition in AD.
Another important aspect of astrocytic hAPP expression in CD44, for example, is predominantly expressed by fibrous astrocytes in white matter (Kaaijk, Pals, Morsink, Bosch, & Troost, 1997) . On the physiological level, corpus callosum astrocytic calcium waves were shown to propagate by a mechanism independent of gap junctional coupling (Schipke, Boucsein, Ohlemeyer, Kirchhoff, & Kettenmann, 2002) , whereas in neocortical grey matter calcium wave propagation does depend on functional astrocytic gap junctions (Haas et al., 2006) .
Astrocytes also express glutamate transporters for clearing the extracellular space of this neurotransmitter. The synapse densitynormalized glutamate transporter activity is significantly higher in white matter than in grey matter (Hassel, Boldingh, Narvesen, Iversen, & Skrede, 2003) . In addition, the capacity for glutamate metabolism to glutamine is higher in white matter than in grey matter astrocytes (Goursaud, Kozlova, Maloteaux, & Hermans, 2009 ) supporting the hypothesis that glutamate clearance might be more important in white matter to avoid excitotoxicity due to glutamate overload. In the Tg2576 mouse model, an age-dependent elongation of magnetic resonance transverse relaxation time (T2) values in the corpus callosum but a significant T2 decrease in grey matter cortex and hippocampus was reported (Kara et al., 2015) . This noninvasive measure is indicative of loss of corpus callosum integrity and was confirmed by histological analyses of demyelination, gliosis and amyloid-plaque deposition in the corpus callosum (Kara et al., 2015) .
In addition to neurons and glial cells, cultured vascular muscle cells from brains of Tg2576 mice were shown to produce hAPP and to deposit Abeta intracellularly, indicating that cerebrovascular amyloid in Tg2576 mice is at least partially of nonneuronal origin and that vascular smooth muscle cells are a source of these amyloid deposits (Frackowiak, Miller, Potempska, Sukontasup, & Mazur-Kolecka, 2003) .
This is also consistent with the expression of endogenous prion protein by muscle cells (Bendheim et al., 1992) .
Together, we here demonstrate that hAPP expression in brains of Tg2576 mice is not restricted to neurons but has a significant astrocytic component, particularly in corpus callosum white matter. These astrocytes may, therefore, contribute to amyloid pathology in Tg2576 mouse brain making them targets for experimental pharmacological intervention studies. Interestingly, astrocytes in the APP/PS1 AD mouse model were also shown to be implicated in disease mechanisms by contributing to neuronal-glial network dysfunction, which can be ameliorated by P2Y1 receptor antagonists (Reichenbach et al., 2018) . Our data underline the importance of investigating cell typespecific transgene expression in hAPP transgenic mouse lines.
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